| ABC | ATP-binding cassette |
| ACAM | Attached-cell Aldefluor method |
| ALDHs | Aldehyde dehydrogenases |
| AML | Acute myeloid leukemia |
| BE | Barrett’s esophagus |
| CAFs | Cancer-associated fibroblasts |
| CAR | Chimeric antigen receptor |
| CSCs | Cancer stem cells |
| CRT | Chemoradiotherapy |
| DDR | DNA damage response |
| EAC | Esophageal adenocarcinoma |
| EC | Esophageal cancer |
| ECSCs | Esophageal cancer stem cells |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial mesenchymal transition |
| ESCC | Esophageal squamous cell carcinoma |
| FACS | Fluorescence-activated cell sorting |
| GEJ | Gastroesophageal junction |
| GERD | Gastroesophageal reflux disease |
| Hh | Hedgehog |
| HIF-1α | Hypoxia-inducible-factor 1α |
| HPV | Human Papillomavirus |
| ICAM1 | Intercellular adhesion molecule1 |
| lncRNA | Long noncoding RNA |
| Gli-1 | Glioma-associated oncogene homolog 1 |
| mAb | Monoclonal antibodies |
| MRD | Minimal residual disease |
| nCRT | Neoadjuvant chemoradiation |
| MAML1 | Mastermind like1 |
| MDR | Multidrug resistance |
| MHC-I | MHC class I molecules |
| REGARD | Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma |
| PDPN | Podoplanin |
| PTCH1 | Patched 1 |
| ROS | Reactive oxygen species |
| RR | Reporter-responsive |
| scRNA-seq | Single-cell RNA sequencing |
| SCs | Stem cells |
| SHH | Sonic Hedgehog |
| SP | Side population |
| SRR2 | Sox2 regulatory region |
| TGF-β | Transforming growths factor-β |
| TME | Tumor microenvironment |
| T-ICs | Tumor-initiating cells |
| YAP | Yes-associated protein |